The role of the TOB1 gene in growth suppression of hepatocellular carcinoma

Lin,Sheyu; Zhu,Qingfeng; Xu,Yang; Liu,Hui; Zhang,Junyu; Xu,Jiawei; Wang,Honglian; Sang,Qing; Xing,Qinghe; Fan,Jia

doi:10.3892/ol.2012.864

The role of the TOB1 gene in growth suppression of hepatocellular carcinoma

Authors:
- Sheyu Lin
- Qingfeng Zhu
- Yang Xu
- Hui Liu
- Junyu Zhang
- Jiawei Xu
- Honglian Wang
- Qing Sang
- Qinghe Xing
- Jia Fan
View Affiliations

Affiliations: Institutes of Biomedical Sciences and Children's Hospital, Fudan University, Shanghai 200032, P.R. China, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China, Henan Cancer Hospital, Zhengzhou University, Zhengzhou 450003, P.R. China
Published online on: August 16, 2012 https://doi.org/10.3892/ol.2012.864
Pages: 981-987

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The TOB1 gene, mapped on 17q21, is a member of the BTG/Tob family. In breast cancer it has been identified as a candidate tumor suppressor gene. However, whether TOB1 is a bona fide tumor suppressor and downregulated in hepatocellular carcinoma (HCC) remains unclear. In addition, whether its expression is regulated through methylation requires investigation. In the present study, we therefore analyzed the expression of TOB1 in HCC and its methylation levels in human HCC and breast cancer. No significant difference in the expression levels of TOB1 was observed between tumor tissues and adjacent normal tissues in HCC. Quantitative methylation analysis by MassArray revealed no significant differences at single CpG sites or in the global promoter region, and all these CpG sites shared a similar methylation pattern in HCC and breast cancer. Moreover, 5‑aza‑2'‑deoxycytidine treatment of three tumor cell lines did not cause elevation of TOB1 mRNA in HepG2 cell lines. Based on these data, we speculate that TOB1 may be a candidate non-tumor suppressor gene in HCC. Furthermore, the clinical outcome was not correlated with TOB1 expression or expression rate. In addition, TOB1 expression or expression rate was not correlated with the overall survival (OS) rates or cumulative recurrence rates. Taken together, we suggest that TOB1 does not act as a tumor suppressor in HCC.

View Figures

View References

1.	M MaekawaE NishidaT TanoueIdentification of the anti-proliferative protein Tob as a MAPK substrateJ Biol Chem2773778337787200210.1074/jbc.M20450620012151396
2.	Y YoshidaE HosodaT NakamuraT YamamotoAssociation of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complexJpn J Cancer Res92592596200110.1111/j.1349-7006.2001.tb01135.x11429045
3.	BS FletcherRW LimBC VarnumDA KujubuRA KoskiHR HerschmanStructure and expression of TIS21, a primary response gene induced by growth factors and tumor promotersJ Biol Chem266145111451819911713584
4.	D TzachanisGJ FreemanN HiranoTob is a negative regulator of activation that is expressed in anergic and quiescent T cellsNat Immunol211741182200110.1038/ni73011694881
5.	JP RouaultR RimokhC TessaBTG1, a member of a new family of antiproliferative genesEMBO J111663167019921373383
6.	JP RouaultN FaletteF GuehenneuxIdentification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathwayNat Genet14482486199610.1038/ng1296-4828944033
7.	A BradburyR PossentiEM ShooterF TironeMolecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarizationProc Natl Acad Sci USA8833533357199110.1073/pnas.88.8.33531849653
8.	M MaekawaT YamamotoE NishidaRegulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequencesExp Cell Res2955965200410.1016/j.yexcr.2003.12.016
9.	T SuzukiJ K-TsuzukuR AjimaT NakamuraY YoshidaT YamamotoPhosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformationGenes Dev1613561370200210.1101/gad.96280212050114
10.	J Kawamura-TsuzukuT SuzukiY YoshidaT YamamotoNuclear localization of Tob is important for regulation of its antiproliferative activityOncogene2366306638200410.1038/sj.onc.120789015235587
11.	S MatsudaJ Kawamura-TsuzukuM OhsugiTob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activityOncogene1270571319968632892
12.	S O’MalleyH SuT ZhangC NgH GeCK TangTOB suppresses breast cancer tumorigenesisInt J Cancer125180518132009
13.	K IwanagaN SueokaA SatoAlteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancerCancer Lett2027179200310.1016/j.canlet.2003.08.01914643028
14.	Y YoshidaS TanakaH UmemoriNegative regulation of BMP/Smad signaling by Tob in osteoblastsCell10310851097200010.1016/S0092-8674(00)00211-711163184
15.	Y YoshidaA von BubnoffN IkematsuTob proteins enhance inhibitory Smad-receptor interactions to repress BMP signalingMech Dev120629637200310.1016/S0925-4773(03)00020-012782279
16.	B XiongY RuiM ZhangTob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional activityDev Cell11225238200610.1016/j.devcel.2006.06.01216890162
17.	N EzzeddineTC ChangW ZhuHuman TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylationMol Cell Biol2777917801200710.1128/MCB.01254-07
18.	Y YoshidaT NakamuraM KomodaMice lacking a transcriptional corepressor Tob are predisposed to cancerGenes Dev1712011206200310.1101/gad.108800312756225
19.	H LiuQ KongB LiY HeP LiB JiaExpression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancerTumour Biol33267273201210.1007/s13277-011-0279-x22125029
20.	Q GaoSJ QiuJ FanIntratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resectionJ Clin Oncol2525862593200710.1200/JCO.2006.09.456517577038
21.	Y ZhaoX KongX LiMetadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cellsPLoS One6e29363201110.1371/journal.pone.002936322195048
22.	JM LlovetAM Di BisceglieJ BruixDesign and endpoints of clinical trials in hepatocellular carcinomaJ Natl Cancer Inst100698711200810.1093/jnci/djn134
23.	J TostDNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarkerMol Biotechnol447181201010.1007/s12033-009-9216-2
24.	L RuanM OsawaN HosodaQuantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulationJ Biol Chem2852762427631201010.1074/jbc.M110.138867